NeuroPace to Present at the Leerink Global Healthcare Conference
NeuroPaceNeuroPace(US:NPCE) Businesswire·2026-03-05 21:30

Core Viewpoint - NeuroPace, Inc. is set to present at the Leerink 2026 Global Healthcare Conference, highlighting its focus on transforming the lives of individuals with epilepsy through innovative medical devices [1] Company Overview - NeuroPace, Inc. is based in Mountain View, California, and specializes in medical devices aimed at reducing or eliminating seizures in epilepsy patients [1] - The company’s RNS System is the first and only commercially available brain-responsive platform that provides personalized, real-time treatment at the source of seizures [1] Financial Performance - For the fourth quarter of 2025, NeuroPace reported total revenue of $26.6 million, marking a 24% increase compared to the fourth quarter of 2024 [1] - Revenue from the RNS System reached $22.4 million, reflecting a growth of 26% compared to the same period in the previous year [1]

NeuroPace to Present at the Leerink Global Healthcare Conference - Reportify